Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 201

1.

Author Correction: Hepatorenal syndrome.

Ginès P, Solà E, Angeli P, Wong F, Nadim MK, Kamath PS.

Nat Rev Dis Primers. 2018 Oct 15;4(1):33. doi: 10.1038/s41572-018-0035-2.

PMID:
30323303
2.

Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study.

Fabrellas N, Hernández R, Graupera I, Solà E, Ramos P, Martín N, Sáez G, Simón C, Pérez A, Graell T, Larrañaga A, Garcia M, de la Arada A, Juanola A, Coiduras A, Duaso I, Casado A, Martin J, Ginès M, Moreno N, Gema Perez A, Marti L, Bernat M, Sola M, Olivé C, Solé C, Ginès P.

PLoS One. 2018 Sep 18;13(9):e0200656. doi: 10.1371/journal.pone.0200656. eCollection 2018.

3.

Hepatorenal syndrome.

Ginès P, Solà E, Angeli P, Wong F, Nadim MK, Kamath PS.

Nat Rev Dis Primers. 2018 Sep 13;4(1):23. doi: 10.1038/s41572-018-0022-7. Review. Erratum in: Nat Rev Dis Primers. 2018 Oct 15;4(1):33.

PMID:
30213943
4.

Cadmium alters heat shock protein pathways in SN56 cholinergic neurons, leading to Aβ and phosphorylated Tau protein generation and cell death.

Moyano P, García JM, Lobo M, Anadón MJ, Sola E, Pelayo A, García J, Frejo MT, Pino JD.

Food Chem Toxicol. 2018 Nov;121:297-308. doi: 10.1016/j.fct.2018.09.016. Epub 2018 Sep 11.

PMID:
30213552
5.

Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial.

Solà E, Solé C, Simón-Talero M, Martín-Llahí M, Castellote J, Garcia-Martínez R, Moreira R, Torrens M, Márquez F, Fabrellas N, de Prada G, Huelin P, Lopez Benaiges E, Ventura M, Manríquez M, Nazar A, Ariza X, Suñé P, Graupera I, Pose E, Colmenero J, Pavesi M, Guevara M, Navasa M, Xiol X, Córdoba J, Vargas V, Ginès P.

J Hepatol. 2018 Aug 21. pii: S0168-8278(18)32285-2. doi: 10.1016/j.jhep.2018.08.006. [Epub ahead of print]

PMID:
30138685
6.

Mitochondrial DNA Haplogroup JT is Related to Impaired Glycaemic Control and Renal Function in Type 2 Diabetic Patients.

Diaz-Morales N, Lopez-Domenech S, Iannantuoni F, Lopez-Gallardo E, Sola E, Morillas C, Rocha M, Ruiz-Pesini E, Victor VM.

J Clin Med. 2018 Aug 16;7(8). pii: E220. doi: 10.3390/jcm7080220.

7.

Erratum to «Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline» [Gastroenterol Hepatol. 2018;41(5):328-349].

Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, López Miranda J, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego-Durán R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M.

Gastroenterol Hepatol. 2018 Aug - Sep;41(7):475-476. doi: 10.1016/j.gastrohep.2018.05.011. English, Spanish. No abstract available.

PMID:
29929828
8.

C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.

Alonso-Titos J, Perea-Ortega L, Sola E, Torres-Rueda A, León M, Toledo R, Duarte AD, Vazquez T, Martinez-Esteban MD, Bailen A, Ruiz-Esteban P, Hernandez D.

BMC Nephrol. 2018 Jun 8;19(1):129. doi: 10.1186/s12882-018-0927-0.

9.

Does Glycemic Control Modulate the Impairment of NLRP3 Inflammasome Activation in Type 2 Diabetes?

Iannantuoni F, Diaz-Morales N, Escribano-Lopez I, Sola E, Roldan-Torres I, Apostolova N, Bañuls C, Rovira-Llopis S, Rocha M, Victor VM.

Antioxid Redox Signal. 2018 Jul 13. doi: 10.1089/ars.2018.7582. [Epub ahead of print]

PMID:
29860862
10.

Hepatorenal syndrome in the era of acute kidney injury.

Solé C, Pose E, Solà E, Ginès P.

Liver Int. 2018 May 30. doi: 10.1111/liv.13893. [Epub ahead of print] Review.

PMID:
29845739
11.

SN56 neuronal cell death after 24 h and 14 days chlorpyrifos exposure through glutamate transmission dysfunction, increase of GSK-3β enzyme, β-amyloid and tau protein levels.

Moyano P, Frejo MT, Anadon MJ, García JM, Díaz MJ, Lobo M, Sola E, García J, Del Pino J.

Toxicology. 2018 Jun 1;402-403:17-27. doi: 10.1016/j.tox.2018.04.003. Epub 2018 Apr 14.

PMID:
29665406
12.

Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline.

Aller R, Fernández-Rodríguez C, Lo Iacono O, Bañares R, Abad J, Carrión JA, García-Monzón C, Caballería J, Berenguer M, Rodríguez-Perálvarez M, Miranda JL, Vilar-Gómez E, Crespo J, García-Cortés M, Reig M, Navarro JM, Gallego R, Genescà J, Arias-Loste MT, Pareja MJ, Albillos A, Muntané J, Jorquera F, Solà E, Hernández-Guerra M, Rojo MÁ, Salmerón J, Caballería L, Diago M, Molina E, Bataller R, Romero-Gómez M.

Gastroenterol Hepatol. 2018 May;41(5):328-349. doi: 10.1016/j.gastrohep.2017.12.003. Epub 2018 Apr 7. English, Spanish. Erratum in: Gastroenterol Hepatol. 2018 Aug - Sep;41(7):475-476.

PMID:
29631866
13.

CXCR3+ Monocytes Increase Significantly in Graft Blood Compared to Peripheral Blood in Patients With Stable Kidney Graft Function.

Caballero A, Palma E, Ruiz-Esteban P, Vazquez T, Sola E, Torio A, Cabello M, Lopez V, Jironda C, Duarte A, Alonso-Titos J, Hernández D.

Transplant Proc. 2018 Mar;50(2):555-559. doi: 10.1016/j.transproceed.2017.11.055.

PMID:
29579851
14.

Mortality in Elderly Waiting-List Patients Versus Age-Matched Kidney Transplant Recipients: Where is the Risk?

Hernández D, Alonso-Titos J, Armas-Padrón AM, Ruiz-Esteban P, Cabello M, López V, Fuentes L, Jironda C, Ros S, Jiménez T, Gutiérrez E, Sola E, Frutos MA, González-Molina M, Torres A.

Kidney Blood Press Res. 2018;43(1):256-275. doi: 10.1159/000487684. Epub 2018 Feb 22. Review.

15.

Editorial: macrophage activation markers predict prognosis and decompensation in patients with cirrhosis-linking gut permeability, inflammation and cirrhosis progression.

Solé C, Pose E, Solà E.

Aliment Pharmacol Ther. 2018 Mar;47(6):851-853. doi: 10.1111/apt.14523. No abstract available.

PMID:
29446139
16.

Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.

Piano S, Schmidt HH, Ariza X, Amoros A, Romano A, Hüsing-Kabar A, Solà E, Gerbes A, Bernardi M, Alessandria C, Scheiner B, Tonon M, Maschmeier M, Solè C, Trebicka J, Gustot T, Nevens F, Arroyo V, Gines P, Angeli P; EASL CLIF Consortium, European Foundation for the Study of Chronic Liver Failure (EF Clif).

Clin Gastroenterol Hepatol. 2018 Jan 31. pii: S1542-3565(18)30105-8. doi: 10.1016/j.cgh.2018.01.035. [Epub ahead of print]

PMID:
29391267
17.

Copeptin in acute decompensation of liver cirrhosis: relationship with acute-on-chronic liver failure and short-term survival.

Kerbert AJC, Verspaget HW, Navarro ÀA, Jalan R, Solà E, Benten D, Durand F, Ginès P, van der Reijden JJ, van Hoek B, Coenraad MJ; CANONIC Study Investigators of the EASL-CLIF Consortium.

Crit Care. 2017 Dec 21;21(1):321. doi: 10.1186/s13054-017-1894-8.

18.

Cadmium induced ROS alters M1 and M3 receptors, leading to SN56 cholinergic neuronal loss, through AChE variants disruption.

Moyano P, de Frias M, Lobo M, Anadon MJ, Sola E, Pelayo A, Díaz MJ, Frejo MT, Del Pino J.

Toxicology. 2018 Feb 1;394:54-62. doi: 10.1016/j.tox.2017.12.006. Epub 2017 Dec 15.

PMID:
29253600
19.

Does Metformin Modulate Endoplasmic Reticulum Stress and Autophagy in Type 2 Diabetic Peripheral Blood Mononuclear Cells?

Diaz-Morales N, Iannantuoni F, Escribano-Lopez I, Bañuls C, Rovira-Llopis S, Sola E, Rocha M, Hernandez-Mijares A, Victor VM.

Antioxid Redox Signal. 2018 Jun 10;28(17):1562-1569. doi: 10.1089/ars.2017.7409. Epub 2017 Nov 28.

PMID:
29061071
20.

Cell death markers in patients with cirrhosis and acute decompensation.

Macdonald S, Andreola F, Bachtiger P, Amoros A, Pavesi M, Mookerjee R, Zheng YB, Gronbaek H, Gerbes AL, Sola E, Caraceni P, Moreau R, Gines P, Arroyo V, Jalan R.

Hepatology. 2018 Mar;67(3):989-1002. doi: 10.1002/hep.29581. Epub 2018 Jan 24.

PMID:
29023872

Supplemental Content

Loading ...
Support Center